Nichols C - Search Results

1

CODE (cisplatin, vincristine, doxorubicin, etoposide) plus granulocyte colony-stimulating factor in advanced non-small-cell lung cancer: a Hoosier Oncology Group phase II trial.

Sandler A, Blanke C, Monaco F, Carey MA, Ansari R, Fisher B, Spiridonidis CH, Einhorn L, Nichols C. Sandler A, et al. Among authors: nichols c. Am J Clin Oncol. 1998 Jun;21(3):294-7. doi: 10.1097/00000421-199806000-00019. Am J Clin Oncol. 1998. PMID: 9626802 Clinical Trial.

2

Management strategies and outcomes of germ cell tumor patients with very high human chorionic gonadotropin levels.

Zon RT, Nichols C, Einhorn LH. Zon RT, et al. Among authors: nichols c. J Clin Oncol. 1998 Apr;16(4):1294-7. doi: 10.1200/JCO.1998.16.4.1294. J Clin Oncol. 1998. PMID: 9552028

3

First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis.

Bokemeyer C, Kollmannsberger C, Meisner C, Harstrick A, Beyer J, Metzner B, Hartmann JT, Schmoll HJ, Einhorn L, Kanz L, Nichols C. Bokemeyer C, et al. Among authors: nichols c. J Clin Oncol. 1999 Nov;17(11):3450-6. doi: 10.1200/JCO.1999.17.11.3450. J Clin Oncol. 1999. PMID: 10550141

4

First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases.

Kollmannsberger C, Nichols C, Bamberg M, Hartmann JT, Schleucher N, Beyer J, Schöfski P, Derigs G, Rüther U, Böhlke I, Schmoll HJ, Kanz L, Bokemeyer C. Kollmannsberger C, et al. Among authors: nichols c. Ann Oncol. 2000 May;11(5):553-9. doi: 10.1023/a:1008388328809. Ann Oncol. 2000. PMID: 10907948 Free article. Clinical Trial.

5

Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease.

Vose JM, Sharp G, Chan WC, Nichols C, Loh K, Inwards D, Rifkin R, Bierman PJ, Lynch JC, Weisenburger DD, Kessinger A, Armitage JO. Vose JM, et al. Among authors: nichols c. J Clin Oncol. 2002 May 1;20(9):2344-52. doi: 10.1200/JCO.2002.09.138. J Clin Oncol. 2002. PMID: 11981006 Clinical Trial.

6

Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.

Motzer RJ, Nichols CJ, Margolin KA, Bacik J, Richardson PG, Vogelzang NJ, Bajorin DF, Lara PN Jr, Einhorn L, Mazumdar M, Bosl GJ. Motzer RJ, et al. J Clin Oncol. 2007 Jan 20;25(3):247-56. doi: 10.1200/JCO.2005.05.4528. J Clin Oncol. 2007. PMID: 17235042 Clinical Trial.

7

Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma.

Freedman A, Neelapu SS, Nichols C, Robertson MJ, Djulbegovic B, Winter JN, Bender JF, Gold DP, Ghalie RG, Stewart ME, Esquibel V, Hamlin P. Freedman A, et al. Among authors: nichols c. J Clin Oncol. 2009 Jun 20;27(18):3036-43. doi: 10.1200/JCO.2008.19.8903. Epub 2009 May 4. J Clin Oncol. 2009. PMID: 19414675 Free PMC article. Clinical Trial.

8

Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery.

Kollmannsberger C, Daneshmand S, So A, Chi KN, Murray N, Moore C, Hayes-Lattin B, Nichols C. Kollmannsberger C, et al. Among authors: nichols c. J Clin Oncol. 2010 Feb 1;28(4):537-42. doi: 10.1200/JCO.2009.23.0755. Epub 2009 Dec 21. J Clin Oncol. 2010. PMID: 20026807

9

Active idiotypic vaccination versus control immunotherapy for follicular lymphoma.

Levy R, Ganjoo KN, Leonard JP, Vose JM, Flinn IW, Ambinder RF, Connors JM, Berinstein NL, Belch AR, Bartlett NL, Nichols C, Emmanouilides CE, Timmerman JM, Gregory SA, Link BK, Inwards DJ, Freedman AS, Matous JV, Robertson MJ, Kunkel LA, Ingolia DE, Gentles AJ, Liu CL, Tibshirani R, Alizadeh AA, Denney DW Jr. Levy R, et al. Among authors: nichols c. J Clin Oncol. 2014 Jun 10;32(17):1797-803. doi: 10.1200/JCO.2012.43.9273. Epub 2014 May 5. J Clin Oncol. 2014. PMID: 24799467 Free PMC article. Clinical Trial.

10

Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?

Einhorn LH, Adra N, Hanna N, Nichols C. Einhorn LH, et al. Among authors: nichols c. J Clin Oncol. 2020 Sep 10;38(26):3073-3074. doi: 10.1200/JCO.20.00702. Epub 2020 Jul 7. J Clin Oncol. 2020. PMID: 32634334 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,369 results

Search Page

Filters